Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/07/071526
CTRI/2024/07/071526
Not yet recruiting
Phase 4

An in-Vivo Study to Determine the Sun Protection Factor of Mamaearth Vitamin C Daily Glow Sunscreen SPF 50 - NI

Honasa Consumer Limited0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Honasa Consumer Limited
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Pms

Investigators

Sponsor
Honasa Consumer Limited

Eligibility Criteria

Inclusion Criteria

  • •1\. Voluntary man or women between 18 and 65 years.
  • •2\. Photo type III to V.
  • •3\. Having apparently healthy skin on test area
  • •4\. For whom the investigator considers that the compliance will be correct.
  • •5\. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
  • •6\. Having signed a Consent Form.
  • •7\. Willingness to avoid intense UV exposure on test site (sun or artificial UV) during the course of the study.
  • •8\. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna), during the course of the study.
  • •9\. Should be able to read and write (in English, Hindi or local language).
  • •10\. Having valid proof of identity and age.

Exclusion Criteria

  • •1\. Pregnant or nursing mothers
  • •2\.Scars, excessive terminal hair or tattoo on the studied area
  • •3\.Henna tattoo anywhere on the body (in case of studies involving hair dyes)
  • •4\.Dermatological infection or pathology on the level of studied area
  • •5\.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye)
  • •6\.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures
  • •7\.Chronic illness which may influence the outcome of the study
  • •8\.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month)
  • •9\.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
Determine Sun Protection Factor of N.G Vitamin C Sunscreen- AP4F067
CTRI/2024/07/071549G Electro Product Private Limited
Not yet recruiting
Phase 4
Determine the Sun Protection Factor of NG Sunscree
CTRI/2024/04/066480G Electro Product Pvt Ltd
Not yet recruiting
Phase 4
Determine the sun protection factor of the Hyaluronic Sunscreen Aqua Gel.
CTRI/2024/04/066534Honasa Consumer Ltd.
Not yet recruiting
Phase 4
Determine the sun protection factor of the Hyaluronic Long Lasting Sunscreen.
CTRI/2024/04/066540Honasa Consumer Ltd.
Not yet recruiting
Phase 4
Determine the sun protection factor of the Mamaearth Vitamin C Daily Glow Sunscreen.
CTRI/2024/04/066537Honasa Consumer Ltd.